Among patients with clinically diagnosed PD who were enrolled in PD trials, around 10%–15% have been found to have normal DAT SPECT findings, also referred to as scans without evidence of dopaminergic deficit (33). This evidence concerns the gene SLC6A3 and Parkinson disease.